Review Article
Therapeutic Evidence of Human Mesenchymal Stem Cell Transplantation for Cerebral Palsy: A Meta-Analysis of Randomized Controlled Trials
Table 3
Adverse event analysis between the hMSC therapy group and the control group.
| AE | Study | RR and 95% CI | |
| Upper respiratory infection | 2 [12, 13] | RR (0.80), 95% CI (0.34-1.87) | 0.60 | Diarrhea | 2 [12, 13] | RR (0.81), 95% CI (0.42-1.57) | 0.53 | Constipation | 2 [12, 13] | RR (0.59), 95% CI (0.13-2.62) | 0.59 |
|
|